Literature DB >> 24302705

Change of psychological distress and physical disability in patients with rheumatoid arthritis over the last two decades.

Cécile L Overman1, Maud S Jurgens, Ercolie R Bossema, Johannes W G Jacobs, Johannes W J Bijlsma, Rinie Geenen.   

Abstract

OBJECTIVE: During the past decades, a more cautious approach with respect to prescribing medication and physical exercise progressed toward evidence-based guidelines regarding the management of rheumatoid arthritis (RA). Currently, physical activity and other means to improve well-being and functioning are encouraged, and the disease is targeted earlier with more intensive and aggressive pharmacologic treatment. The current study examined whether psychological distress and physical disability in patients with RA reduced over the last 2 decades and whether this is explained by a reduction of disease activity.
METHODS: From 1990-2011, consecutive patients with RA (n = 1,151, age range 17-86 years, 68% female, 62% rheumatoid factor positive) were monitored at diagnosis and after 3-5 years of treatment (followup). Depressed mood, anxiety, and physical disability were predicted in multiple linear regression analyses by year of assessment, disease activity, and patient demographics.
RESULTS: Over the decades, depressed mood (P = 0.01), anxiety (P = 0.001), and physical disability (P = 0.02) reduced at diagnosis and within-treatment improvement of anxiety (P = 0.04) and physical disability (P < 0.001) increased. Percentages of patients with depressed mood, anxiety, and physical disability at followup changed from 25%, 23%, and 53%, respectively, 2 decades ago to 14%, 12%, and 31%, respectively, currently. After taking account of reduction in disease activity, the decrease in physical disability remained significant (P < 0.001).
CONCLUSION: Over the last 2 decades, psychological distress and physical disability decreased. This favorable trend might partly be due to reduced disease activity. The results indicate that patients with RA have a better opportunity to live a valued life currently than 20 years ago.
Copyright © 2014 by the American College of Rheumatology.

Entities:  

Mesh:

Year:  2014        PMID: 24302705     DOI: 10.1002/acr.22211

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  8 in total

1.  2019 Update of the American College of Rheumatology Recommended Rheumatoid Arthritis Disease Activity Measures.

Authors:  Bryant R England; Benedict K Tiong; Martin J Bergman; Jeffrey R Curtis; Salahuddin Kazi; Ted R Mikuls; James R O'Dell; Veena K Ranganath; Alex Limanni; Lisa G Suter; Kaleb Michaud
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-11-11       Impact factor: 4.794

Review 2.  Glucocorticoid-induced osteoporosis: who to treat with what agent?

Authors:  René Rizzoli; Emmanuel Biver
Journal:  Nat Rev Rheumatol       Date:  2014-11-11       Impact factor: 20.543

3.  A prospective pilot study to evaluate an animated home-based physical exercise program as a treatment option for patients with rheumatoid arthritis.

Authors:  Jan Zernicke; Claudia Kedor; Angela Müller; Gerd-Rüdiger Burmester; Anett Reißhauer; Eugen Feist
Journal:  BMC Musculoskelet Disord       Date:  2016-08-18       Impact factor: 2.362

4.  Validation of the dutch version of the health education impact questionnaire (HEIQ) and comparison of the Dutch translation with the English, German and French HEIQ.

Authors:  Judy W Ammerlaan; Harmieke van Os-Medendorp; Jacob K Sont; Gerald R Elsworth; Richard H Osborne
Journal:  Health Qual Life Outcomes       Date:  2017-01-31       Impact factor: 3.186

5.  Determinants of happiness and quality of life in patients with rheumatoid arthritis: a structural equation modelling approach.

Authors:  Eduardo José Ferreira Santos; Cátia Duarte; Ricardo J O Ferreira; Ana Margarida Pinto; Rinie Geenen; Jose A P da Silva
Journal:  Ann Rheum Dis       Date:  2018-04-06       Impact factor: 19.103

6.  B cells inhibit bone formation in rheumatoid arthritis by suppressing osteoblast differentiation.

Authors:  Wen Sun; Nida Meednu; Alexander Rosenberg; Javier Rangel-Moreno; Victor Wang; Jason Glanzman; Teresa Owen; Xichao Zhou; Hengwei Zhang; Brendan F Boyce; Jennifer H Anolik; Lianping Xing
Journal:  Nat Commun       Date:  2018-12-03       Impact factor: 14.919

7.  Impact of clinical and psychological factors associated with depression in patients with rheumatoid arthritis: comparative study between Germany and Brazil.

Authors:  Harriet Morf; Geraldo da Rocha Castelar-Pinheiro; Ana Beatriz Vargas-Santos; Christoph Baerwald; Olga Seifert
Journal:  Clin Rheumatol       Date:  2020-10-26       Impact factor: 2.980

8.  Secular changes in the progression of clinical markers and patient-reported outcomes in early rheumatoid arthritis.

Authors:  Lewis Carpenter; Elena Nikiphorou; Patrick D W Kiely; David A Walsh; Adam Young; Sam Norton
Journal:  Rheumatology (Oxford)       Date:  2020-09-01       Impact factor: 7.580

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.